BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37987202)

  • 1. FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.
    Xing X; Liu M; Wang X; Guo Q; Wang H; Wang W
    J Cell Mol Med; 2024 Jan; 28(1):e18041. PubMed ID: 37987202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
    Meng H; Zhao B; Wang Y
    Exp Mol Pathol; 2020 Aug; 115():104451. PubMed ID: 32417392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.
    Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q
    Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
    Shi X; Cui Z; Liu X; Wu S; Wu Y; Fang F; Zhao H
    Biochem Biophys Res Commun; 2019 Mar; 510(4):594-600. PubMed ID: 30739786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLAGL2 Promotes the Proliferation and Migration of Diffuse Large B-cell Lymphoma Cells via Wnt/β-catenin Pathway.
    Jin W; Wang X
    Ann Clin Lab Sci; 2022 May; 52(3):359-366. PubMed ID: 35777795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
    Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
    Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling.
    Hu S; Ren S; Cai Y; Liu J; Han Y; Zhao Y; Yang J; Zhou X; Wang X
    Cell Death Differ; 2022 Mar; 29(3):642-656. PubMed ID: 34743203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma.
    Ge X; Lv X; Feng L; Liu X; Gao J; Chen N; Wang X
    PLoS One; 2012; 7(6):e39449. PubMed ID: 22768080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
    Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
    Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G protein nucleolar 3 promotes Non-Hodgkin lymphoma progression by activating the Wnt/β-catenin signaling pathway.
    Dai R; Wu M; Zhang Y; Zhu Z; Shi J
    Exp Cell Res; 2021 Dec; 409(2):112911. PubMed ID: 34762898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
    Walker MP; Stopford CM; Cederlund M; Fang F; Jahn C; Rabinowitz AD; Goldfarb D; Graham DM; Yan F; Deal AM; Fedoriw Y; Richards KL; Davis IJ; Weidinger G; Damania B; Major MB
    Sci Signal; 2015 Feb; 8(362):ra12. PubMed ID: 25650440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIMD4 exhibits regulatory capability on the proliferation and apoptosis of diffuse large B-cell lymphoma cells via the Wnt/β-catenin pathway.
    Li Y; Zhang PY; Yang ZW; Ma F; Li FX
    J Gene Med; 2020 Aug; 22(8):e3186. PubMed ID: 32187802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3 ubiquitin ligase neural precursor cell-expressed developmentally downregulated gene 4 motivates FOXA1 ubiquitination and restrains proliferation of diffuse large B-cell lymphoma cells via the Wnt/β-Catenin pathway.
    Yang L; Li JN
    Cell Biol Int; 2023 Oct; 47(10):1688-1701. PubMed ID: 37415495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing Aurora-kinase-A (AURKA) reinforced the sensitivity of diffuse large B-cell lymphoma cells to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) via suppressing β-Catenin and RAS-extracellular signal-regulated protein kinase (ERK1/2) pathway.
    Wang S; Sun L
    Bioengineered; 2021 Dec; 12(1):8296-8308. PubMed ID: 34565287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression and nuclear localization of β-catenin in diffuse large B-cell lymphoma.
    Ge X; Lv X; Feng L; Liu X; Wang X
    Mol Med Rep; 2012 Jun; 5(6):1433-7. PubMed ID: 22427053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.
    Bognar MK; Vincendeau M; Erdmann T; Seeholzer T; Grau M; Linnemann JR; Ruland J; Scheel CH; Lenz P; Ott G; Lenz G; Hauck SM; Krappmann D
    Oncogene; 2016 Aug; 35(32):4269-81. PubMed ID: 26776161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting effects of calponin 3 on the growth of diffuse large B‑cell lymphoma cells.
    Xing X; Liu M; Wang X; Guo Q; Wang H
    Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36660952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A circular RNA from
    Hu Y; Zhao Y; Shi C; Ren P; Wei B; Guo Y; Ma J
    Aging (Albany NY); 2019 Oct; 11(19):8068-8084. PubMed ID: 31631067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras interacting protein 1 facilitated proliferation and invasion of diffuse large B-cell lymphoma cells.
    Xing X; Wang X; Liu M; Guo Q; Wang H
    Cancer Biol Ther; 2023 Dec; 24(1):2193114. PubMed ID: 36967521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism Underlying the Inhibitory Effect of MiR-532-3p on the Cells Proliferation of Diffuse Large B-Cell Lymphoma].
    Zhang Y; Yao Q; Jin JJ; Xi YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1423-1427. PubMed ID: 36208244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.